Nifty
Sensex
:
:
25149.85
82500.47
-205.40 (-0.81%)
-689.81 (-0.83%)

Pharmaceuticals & Drugs - API

Rating :
N/A

BSE: 506235 | NSE: ALEMBICLTD

117.26
11-Jul-2025
  • Open
  • High
  • Low
  • Previous Close
  •  118.05
  •  119.51
  •  116.81
  •  118.72
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  332513
  •  39102153.41
  •  169
  •  85.46

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 3,010.77
  • 9.69
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 3,020.85
  • 2.05%
  • 1.29

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 70.88%
  • 0.82%
  • 21.94%
  • FII
  • DII
  • Others
  • 1.65%
  • 0.00%
  • 4.71%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.69
  • 24.72
  • 20.37

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 31.63
  • 55.13
  • 18.37

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.32
  • 59.88
  • 21.49

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.07
  • 9.31
  • 10.44

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.18
  • 1.20
  • 1.12

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 31.85
  • 34.60
  • 21.02

Earnings Forecasts:

(Updated: 06-06-2025)
Description
2024
2025
2026
2027
Adj EPS
10.46
12.1
P/E Ratio
3.95
3.41
Revenue
147
222
EBITDA
57
94
Net Income
269
311
ROA
11.9
12.9
P/B Ratio
1.31
0.45
ROE
12.6
13.73
FCFF
13
98
FCFF Yield
0.47
3.47
Net Debt
-3
-45
BVPS
31.5
91.07

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Net Sales
60.27
49.04
22.90%
57.92
39.32
47.30%
52.91
32.28
63.91%
50.78
36.84
37.84%
Expenses
32.95
24.89
32.38%
31.52
27.64
14.04%
33.34
22.13
50.66%
30.38
25.97
16.98%
EBITDA
27.32
24.15
13.13%
26.40
11.68
126.03%
19.57
10.15
92.81%
20.40
10.87
87.67%
EBIDTM
45.33%
49.25%
45.58%
29.70%
36.99%
31.44%
40.17%
29.51%
Other Income
2.96
2.04
45.10%
4.37
2.23
95.96%
65.61
47.87
37.06%
1.96
2.63
-25.48%
Interest
0.62
0.48
29.17%
0.69
0.37
86.49%
0.67
0.13
415.38%
0.49
0.13
276.92%
Depreciation
2.75
1.48
85.81%
2.69
2.66
1.13%
2.68
1.86
44.09%
2.50
1.83
36.61%
PBT
26.91
24.23
11.06%
27.39
10.88
151.75%
81.83
56.03
46.05%
19.37
11.54
67.85%
Tax
3.16
2.94
7.48%
1.30
0.96
35.42%
4.52
4.32
4.63%
1.95
1.58
23.42%
PAT
23.75
21.29
11.55%
26.09
9.92
163.00%
77.31
51.71
49.51%
17.42
9.96
74.90%
PATM
39.41%
43.41%
45.04%
25.23%
146.12%
160.19%
34.30%
27.04%
EPS
2.67
2.81
-4.98%
2.55
2.39
6.69%
4.71
3.53
33.43%
2.17
1.73
25.43%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
-
221.89
157.49
127.24
78.22
73.52
73.93
123.81
125.30
147.16
127.53
Net Sales Growth
-
40.89%
23.77%
62.67%
6.39%
-0.55%
-40.29%
-1.19%
-14.85%
15.39%
 
Cost Of Goods Sold
-
69.17
48.95
41.12
22.62
22.24
12.17
54.07
78.50
96.33
69.67
Gross Profit
-
152.72
108.53
86.13
55.60
51.28
61.75
69.74
46.79
50.83
57.86
GP Margin
-
68.83%
68.91%
67.69%
71.08%
69.75%
83.52%
56.33%
37.34%
34.54%
45.37%
Total Expenditure
-
128.18
100.62
86.91
64.29
63.09
70.79
105.74
114.22
140.45
121.53
Power & Fuel Cost
-
2.34
1.18
2.02
0.15
0.42
0.91
2.34
1.11
5.46
13.26
% Of Sales
-
1.05%
0.75%
1.59%
0.19%
0.57%
1.23%
1.89%
0.89%
3.71%
10.40%
Employee Cost
-
27.31
23.03
24.04
21.47
22.60
20.79
20.52
19.64
22.83
23.79
% Of Sales
-
12.31%
14.62%
18.89%
27.45%
30.74%
28.12%
16.57%
15.67%
15.51%
18.65%
Manufacturing Exp.
-
11.25
10.92
7.02
8.30
5.91
25.52
20.00
6.08
7.11
5.77
% Of Sales
-
5.07%
6.93%
5.52%
10.61%
8.04%
34.52%
16.15%
4.85%
4.83%
4.52%
General & Admin Exp.
-
12.24
11.85
8.90
9.12
6.63
8.30
7.15
6.80
6.48
5.30
% Of Sales
-
5.52%
7.52%
6.99%
11.66%
9.02%
11.23%
5.77%
5.43%
4.40%
4.16%
Selling & Distn. Exp.
-
1.84
2.19
1.90
0.69
0.92
0.87
0.11
0.34
0.90
2.11
% Of Sales
-
0.83%
1.39%
1.49%
0.88%
1.25%
1.18%
0.09%
0.27%
0.61%
1.65%
Miscellaneous Exp.
-
4.03
2.50
1.90
1.93
4.37
2.23
1.56
1.75
1.33
2.11
% Of Sales
-
1.82%
1.59%
1.49%
2.47%
5.94%
3.02%
1.26%
1.40%
0.90%
1.29%
EBITDA
-
93.71
56.87
40.33
13.93
10.43
3.14
18.07
11.08
6.71
6.00
EBITDA Margin
-
42.23%
36.11%
31.70%
17.81%
14.19%
4.25%
14.59%
8.84%
4.56%
4.70%
Other Income
-
74.89
54.77
64.26
89.18
10.92
93.54
29.45
37.04
30.97
28.81
Interest
-
2.47
1.11
0.47
0.39
0.36
0.29
0.22
0.17
0.16
0.12
Depreciation
-
10.63
7.84
6.72
4.86
3.94
3.23
2.63
3.78
5.09
6.14
PBT
-
155.50
102.69
97.41
97.86
17.04
93.17
44.67
44.18
32.44
28.55
Tax
-
10.93
9.82
6.18
11.66
3.20
0.13
3.59
2.39
-0.86
0.61
Tax Rate
-
7.03%
9.56%
7.12%
11.91%
18.78%
0.14%
8.04%
5.41%
-3.23%
2.41%
PAT
-
144.57
92.87
80.62
86.19
13.84
93.03
41.08
41.78
27.49
24.72
PAT before Minority Interest
-
144.57
92.87
80.62
86.19
13.84
93.03
41.08
41.78
27.49
24.72
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
65.15%
58.97%
63.36%
110.19%
18.82%
125.84%
33.18%
33.34%
18.68%
19.38%
PAT Growth
-
55.67%
15.19%
-6.46%
522.76%
-85.12%
126.46%
-1.68%
51.98%
11.21%
 
EPS
-
5.63
3.62
3.14
3.36
0.54
3.62
1.60
1.63
1.07
0.96

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
2,338.59
2,185.56
2,078.03
2,496.58
2,297.03
1,418.04
1,208.53
1,085.77
911.43
803.13
Share Capital
51.36
51.36
51.36
51.36
51.36
51.36
51.36
53.41
53.41
53.41
Total Reserves
2,287.23
2,134.21
2,026.68
2,445.23
2,245.67
1,366.69
1,157.17
1,032.37
858.02
749.72
Non-Current Liabilities
53.94
52.89
42.74
67.60
52.52
6.88
8.52
14.15
12.61
14.69
Secured Loans
10.67
7.39
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
2.44
1.91
1.21
1.10
0.83
0.70
0.72
0.80
0.78
0.64
Current Liabilities
127.59
96.11
89.56
67.76
59.41
45.80
48.80
59.12
68.34
57.68
Trade Payables
28.26
31.02
17.38
19.27
17.81
12.99
24.75
16.42
14.76
16.36
Other Current Liabilities
55.39
33.10
45.05
35.54
30.67
22.07
8.07
31.82
39.20
27.37
Short Term Borrowings
0.00
0.00
0.00
0.00
0.28
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
43.94
31.99
27.13
12.96
10.66
10.74
15.97
10.89
14.38
13.95
Total Liabilities
2,520.12
2,334.56
2,210.33
2,631.94
2,408.96
1,470.72
1,265.85
1,159.04
992.38
875.50
Net Block
135.38
130.59
131.88
133.55
233.55
209.47
186.88
147.46
147.60
146.42
Gross Block
156.66
151.54
151.21
151.21
256.22
228.24
202.45
160.37
158.33
371.75
Accumulated Depreciation
21.28
20.95
19.33
17.66
22.67
18.78
15.57
12.92
10.73
225.34
Non Current Assets
2,298.14
2,191.38
2,032.45
2,488.63
2,306.87
1,307.90
1,167.08
972.32
801.10
706.29
Capital Work in Progress
0.00
1.10
0.13
0.19
37.27
18.69
22.26
31.64
0.16
0.00
Non Current Investment
1,844.95
1,774.65
1,708.16
2,182.01
2,030.58
1,078.88
957.76
792.85
651.28
558.62
Long Term Loans & Adv.
36.22
36.22
1.22
6.54
1.95
0.86
0.17
0.38
2.05
1.25
Other Non Current Assets
8.02
10.64
1.64
2.67
3.52
0.00
0.00
0.00
0.00
0.00
Current Assets
221.99
143.19
177.89
143.32
102.09
162.82
98.77
186.73
191.28
169.21
Current Investments
55.10
11.34
45.40
25.84
16.59
53.71
43.46
119.85
104.76
46.13
Inventories
99.39
92.60
88.61
86.87
54.28
35.41
35.33
32.41
50.61
74.90
Sundry Debtors
29.97
19.76
23.45
15.22
13.81
8.98
13.51
25.29
21.60
27.98
Cash & Bank
4.37
2.47
1.90
1.85
6.57
58.85
2.01
0.84
2.32
2.34
Other Current Assets
33.16
3.92
8.95
3.89
10.84
5.86
4.47
8.35
11.98
17.87
Short Term Loans & Adv.
26.30
13.10
9.57
9.65
8.73
4.38
2.59
6.34
9.88
16.24
Net Current Assets
94.40
47.08
88.32
75.56
42.68
117.03
49.97
127.61
122.94
111.53
Total Assets
2,520.13
2,334.57
2,210.34
2,631.95
2,408.96
1,470.72
1,265.85
1,159.05
992.38
875.50

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
86.37
22.69
38.85
-17.75
-2.18
6.54
21.51
23.58
51.63
9.65
PBT
155.50
102.69
86.80
97.86
17.04
93.17
44.67
44.18
26.63
25.33
Adjustment
-52.98
-42.09
-52.87
-78.66
1.65
-85.70
-20.51
-28.85
-20.86
-16.51
Changes in Working Capital
-0.60
-38.47
11.44
-27.90
-18.64
0.60
1.99
11.89
46.06
1.70
Cash after chg. in Working capital
101.93
22.12
45.37
-8.70
0.05
8.06
26.15
27.22
51.83
10.52
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-15.56
0.57
-6.52
-9.04
-2.23
-1.53
-4.64
-3.64
-0.20
-0.87
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-26.58
25.84
7.30
18.85
-34.87
56.72
71.67
-22.40
-46.69
-4.76
Net Fixed Assets
-4.02
-1.30
0.06
138.27
-42.74
-22.22
-32.70
-33.47
213.26
344.49
Net Investments
-3.03
92.03
223.30
-144.79
-383.89
7.99
70.53
-63.48
-62.37
-141.47
Others
-19.53
-64.89
-216.06
25.37
391.76
70.95
33.84
74.55
-197.58
-207.78
Cash from Financing Activity
-58.34
-48.19
-46.39
-5.82
-15.36
-6.41
-92.01
-2.66
-4.96
-5.19
Net Cash Inflow / Outflow
1.45
0.33
-0.24
-4.72
-52.41
56.85
1.17
-1.48
-0.02
-0.30
Opening Cash & Equivalents
1.26
0.93
1.17
5.89
58.30
2.01
0.84
2.32
2.34
2.64
Closing Cash & Equivalent
2.71
1.26
0.93
1.17
5.89
58.85
2.01
0.84
2.32
2.34

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
91.07
85.11
80.93
97.23
89.45
55.22
47.06
40.66
34.13
30.08
ROA
5.96%
4.09%
3.33%
3.42%
0.71%
6.80%
3.39%
3.88%
2.94%
3.25%
ROE
6.39%
4.36%
3.52%
3.60%
0.75%
7.08%
3.58%
4.18%
3.21%
3.71%
ROCE
6.95%
4.86%
3.82%
4.10%
0.94%
7.12%
3.91%
4.44%
3.12%
3.82%
Fixed Asset Turnover
1.44
1.04
0.84
0.52
0.30
0.34
0.68
0.80
0.58
0.35
Receivable days
40.90
50.08
55.47
67.74
56.58
55.52
57.19
67.34
59.14
103.47
Inventory Days
157.91
210.00
251.69
329.34
222.67
174.64
99.84
119.22
149.70
216.71
Payable days
156.42
180.44
162.67
299.17
252.73
120.48
74.61
55.73
40.49
60.75
Cash Conversion Cycle
42.40
79.64
144.48
97.90
26.52
109.68
82.42
130.83
168.35
259.43
Total Debt/Equity
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest Cover
63.93
93.63
187.54
252.50
48.08
324.49
207.64
261.78
169.23
221.26

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.